
Keywords: اتیلینیدامین تتراستیک اسید; AAV1; adeno-associated virus serotype 1; AD; Alzheimer's disease; EDTA; ethylenediaminetetraacetic acid; FTD; frontotemporal dementia; GFAP; glial fibrillary acidic protein; GSK3β; glycogen synthase kinase-3β; GTTs; glucose tolerance tests; JAK; Janus